BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33498793)

  • 1. HIV-1
    Kapaata A; Balinda SN; Xu R; Salazar MG; Herard K; Brooks K; Laban K; Hare J; Dilernia D; Kamali A; Ruzagira E; Mukasa F; Gilmour J; Salazar-Gonzalez JF; Yue L; Cotten M; Hunter E; Kaleebu P
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.
    Yu FH; Huang KJ; Wang CT
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31906562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease.
    Kozísek M; Henke S; Sasková KG; Jacobs GB; Schuch A; Buchholz B; Müller V; Kräusslich HG; Rezácová P; Konvalinka J; Bodem J
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4320-30. PubMed ID: 22644035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
    Wanaguru M; Bishop KN
    J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perturbing HIV-1 Ribosomal Frameshifting Frequency Reveals a
    Benner BE; Bruce JW; Kentala JR; Murray M; Becker JT; Garcia-Miranda P; Ahlquist P; Butcher SE; Sherer NM
    J Virol; 2022 Jan; 96(1):e0134921. PubMed ID: 34643428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication.
    Leiherer A; Ludwig C; Wagner R
    J Virol; 2009 Jul; 83(14):7210-20. PubMed ID: 19403679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response.
    Ho SK; Coman RM; Bunger JC; Rose SL; O'Brien P; Munoz I; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 2008 Sep; 378(2):272-81. PubMed ID: 18599104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.
    Naidoo VL; Mann JK; Noble C; Adland E; Carlson JM; Thomas J; Brumme CJ; Thobakgale-Tshabalala CF; Brumme ZL; Brockman MA; Goulder PJR; Ndung'u T
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.
    Farinre O; Gounder K; Reddy T; Tongo M; Hare J; Chaplin B; Gilmour J; Kanki P; Mann JK; Ndung'u T
    Retrovirology; 2021 May; 18(1):11. PubMed ID: 33952315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance.
    Cao J; McNevin J; McSweyn M; Liu Y; Mullins JI; McElrath MJ
    J Virol; 2008 Jan; 82(1):495-502. PubMed ID: 17942528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
    Hsieh SH; Yu FH; Huang KJ; Wang CT
    J Virol; 2023 Sep; 97(9):e0094823. PubMed ID: 37671867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
    Martins AN; Waheed AA; Ablan SD; Huang W; Newton A; Petropoulos CJ; Brindeiro RD; Freed EO
    J Virol; 2016 Jan; 90(2):768-79. PubMed ID: 26512081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa.
    Aralaguppe SG; Winner D; Singh K; Sarafianos SG; Quiñones-Mateu ME; Sönnerborg A; Neogi U
    J Med Virol; 2017 Jan; 89(1):106-111. PubMed ID: 27328744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.
    Kiguoya MW; Mann JK; Chopera D; Gounder K; Lee GQ; Hunt PW; Martin JN; Ball TB; Kimani J; Brumme ZL; Brockman MA; Ndung'u T
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
    Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
    Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.